STAT Plus: Pharmalittle: U.S. hands Glaxo and Sanofi $2.1 billion for a Covid-19 vaccine; Moderna director resigns over conflict concerns
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, not surprisingly, is rather modest. We plan to tackle sundry chores, catch up on some reading and promenade with the official mascot. And what about you? This is a lovely time of year to enjoy the great outdoors. You could reach out to someone who is feeling isolated these days. You could also plan ahead to make sure you are registered to vote, however you may cast your ballot. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …
Elizabeth Nabel, president of Brigham and Women’s Hospital, is resigning from the Moderna (MRNA) board in response to questions about whether her role at the biotech is a conflict of interest since her hospital is participating in a large study of Moderna’s experimental Covid-19 vaccine that just began, The Boston Globe reports. The study is being led partly by a Brigham infectious diseases specialist, who also is helping to run the nationwide testing.
Continue to STAT Plus to read the full story…
